BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 24637863)

  • 21. Kidney transplantation in patients with antibodies against donor HLA class II.
    Pollinger HS; Stegall MD; Gloor JM; Moore SB; Degoey SR; Ploeger NA; Park WD; Pollinger HS; Stegall MD; Gloor JM; Moore SB; Degoey SR; Ploeger NA; Park WD
    Am J Transplant; 2007 Apr; 7(4):857-63. PubMed ID: 17295642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined therapy of deoxyspergualin and plasmapheresis: a useful treatment for antibody-mediated acute rejection after kidney transplantation.
    Nojima M; Yoshimoto T; Nakao A; Maruyama T; Takiuchi H; Izumi M; Hashimoto M; Kyo M; Shima H
    Transplant Proc; 2005 Mar; 37(2):930-3. PubMed ID: 15848578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-GSTT1 antibodies and Null genotype correlate with histological changes of antibody mediated rejection in kidney transplantation.
    Obrișcă B; Leca N; Chou-Wu E; Sibulesky L; Bakthavatsalam R; Kling CE; Alawieh R; Smith KD; Ismail G; Gimferrer I
    Transpl Immunol; 2023 Dec; 81():101943. PubMed ID: 37866670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
    Das A; Rocque B; Remulla D; Raza M; Barbetta A; Bangerth S; Goldbeck C; Maw TT; Kim J; Kwon Y; Emamaullee J
    Transplantation; 2023 May; 107(5):1115-1123. PubMed ID: 36398988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtle Changes in Tacrolimus Levels Have an Impact on Early Donor-Specific Antibodies in Kidney Transplantation.
    Henderson M; Awdishu L; Morris GP; Fabbri K; Shah M; Khan A; Kerr J
    Prog Transplant; 2023 Dec; 33(4):335-340. PubMed ID: 37941352
    [No Abstract]   [Full Text] [Related]  

  • 26. Associations between use of cyclosporine-sparing agents and outcome in kidney transplant recipients.
    McDonald SP; Russ GR
    Kidney Int; 2002 Jun; 61(6):2259-65. PubMed ID: 12028468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.
    Przybylowski P; Balogna M; Radovancevic B; Frazier OH; Susskind B; Van Buren C; Katz S; Kahan BD; Kerman R
    Transplantation; 1999 Jan; 67(2):258-62. PubMed ID: 10075590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of high- and low-risk second kidney grafts.
    Mahoney RJ; Norman DJ; Colombe BW; Garovoy MR; Leeber DA
    Transplantation; 1996 May; 61(9):1349-55. PubMed ID: 8629295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching.
    Bielmann D; Hönger G; Lutz D; Mihatsch MJ; Steiger J; Schaub S
    Am J Transplant; 2007 Mar; 7(3):626-32. PubMed ID: 17352712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal allograft rejection with intimal arteritis: histologic predictors of response to therapy and graft survival.
    Haas M; Kraus ES; Samaniego-Picota M; Racusen LC; Ni W; Eustace JA
    Kidney Int; 2002 Apr; 61(4):1516-26. PubMed ID: 11918760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation.
    El Fettouh HA; Cook DJ; Bishay E; Flechner S; Goldfarb D; Modlin C; Dennis V; Novick AC
    Urology; 2000 Sep; 56(3):369-72. PubMed ID: 10962296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection.
    Woodle ES; Alloway RR; Hanaway MJ; Buell JF; Thomas M; Roy-Chaudhury P; Trofe J
    Transplant Proc; 2005 Mar; 37(2):798-9. PubMed ID: 15848535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.
    Stegall MD; Gloor J; Winters JL; Moore SB; Degoey S
    Am J Transplant; 2006 Feb; 6(2):346-51. PubMed ID: 16426319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
    Flechner SM; Modlin CS; Serrano DP; Goldfarb DA; Papajcik D; Mastroianni B; Goormastic M; Novick AC
    Transplantation; 1996 Nov; 62(9):1235-41. PubMed ID: 8932263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.
    Demir Z; Raynaud M; Aubert O; Debray D; Sebagh M; Duong Van Huyen JP; Del Bello A; Jolivet NC; Paradis V; Durand F; Muratot S; Lozach C; Chardot C; Francoz C; Kamar N; Sarnacki S; Coilly A; Samuel D; Vibert E; Féray C; Lefaucheur C; Loupy A
    Am J Transplant; 2024 Jun; 24(6):954-966. PubMed ID: 38097016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.
    Shapiro R; Zeevi A; Basu A; Tan HP; Kayler LK; Blisard DM; Thai NL; Girnita AL; Randhawa PS; Gray EA; Marcos A; Starzl TE
    Transplantation; 2008 Apr; 85(8):1125-32. PubMed ID: 18431232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocilizumab for antibody-mediated rejection treatment in lung transplantation.
    January SE; Fester KA; Halverson LP; Witt CA; Byers DE; Vazquez-Guillamet R; Alexander-Brett J; Tague LK; Kreisel D; Gelman A; Puri V; Bahena RN; Takahashi T; Hachem RR; Kulkarni HS
    J Heart Lung Transplant; 2023 Oct; 42(10):1353-1357. PubMed ID: 37268051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increased incidence of rejection episodes. One of the causes of worse kidney transplantation survival in black recipients.
    Tesi RJ; Deboisblanc M; Saul C; Frentz G; Etheredge E
    Arch Surg; 1997 Jan; 132(1):35-9; discussion 40. PubMed ID: 9006550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of flowcytometric crossmatching in renal allograft recipients.
    Sridhar NR; Munda R; Balakrishnan K; First MR
    Nephron; 1992; 62(3):262-6. PubMed ID: 1436335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.